Patients with diabetes receiving treatment for CRC may experience more neuropathic symptoms
the ONA take:
Patients with colorectal cancer who also have diabetes experienced more neuropathic symptoms, regardless of cancer treatment, according to a recent study published in the Journal of Cancer Survivorship.
Researchers found that patients with colorectal cancer and diabetes experienced more mild to severe neuropathic symptoms, including tingling fingers or hands, tingling toes or feet, numbness in toes or feet, and erectile dysfunction among men, than patients without diabetes.
The study demonstrated no differences in cancer treatment between patients with colorectal cancer and diabetes compared with those without diabetes.
The authors conclude that diabetes rather than chemotherapy results in more neuropathic symptoms among patients with cancer and diabetes compared with those without diabetes.
The findings ultimately suggest that up to 39% of cancer survivors might expect mostly mild, neuropathic symptoms, with more symptoms occurring in patients with diabetes.
Neuropathic symptoms are typically associated with the chemotherapy agent oxaliplatin, which is often used in combination with fluorouracil, leucovorin, and sometimes irinotecan in the treatment of colorectal cancer.
Patients with colorectal cancer who also have diabetes experienced more neuropathic symptoms, regardless of cancer treatment.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|